The Wall Street Journal names RFK Jr. “dangerous to public health” before the hearings

The Wall Street Journal Editorial Board will issue an opposition to Robert Kennedy Jr., President Trump’s pick to lead the Department of Health and Human Services (HHS).

“Concurrently committing to audit his giant treasury of trade disputes and questionable ideas,” the magazine wrote in an editorial published Sunday ahead of Kennedy’s hearings with the Senate Finance Committee on Wednesday and the Senate Committee on Health, Education, Employment, Treatment, and Employment. Pensions on Thursday.

The newspaper’s board of directors said in the newspaper that it expected Kennedy to “fill his ties with trial lawyers, anti-lawyer views, and support of diverse progressive causes,” while also presenting himself as a truth-teller and killer of government corruption, [even though] He’s as slippery as Anthony Fauci.”

“More troubling is his long record of anti-ermine advocacy,” the magazine wrote, noting that the former presidential candidate “has tried to tone down his vaccine skepticism since he was nominated, and now says he won’t take away anyone’s vaccines.”

Rupert Murdoch’s outlet reported that Kennedy’s financial disclosures show that he “received millions of dollars from referring clients to Wisner Baum and Morgan & Morgan, law firms that have sued vaccine and drug makers.”

“The risk is high that Mr. Kennedy will use his power and platform at HHS to enrich his friends on trial at the expense of public health and medical innovation,” the editorial board wrote. “You would be wiser to believe RFK Jr.’s career of spreading lies rather than his confirmation diversions.”

The magazine has shown a willingness to criticize Trump and his officials in recent years, recently calling out the president for withdrawing security details for former top aides who faced threats from foreign powers.